Kiora Pharmaceuticals

Kiora Pharmaceuticals is viewed by third parties as a clinical-stage biotechnology company operating in the healthcare sector, with a specialized focus on developing therapies for retinal and eye-related diseases. It is primarily engaged in advancing small-molecule treatments designed to target underlying biological pathways that cause vision loss,... particularly in conditions with limited existing treatment options. The company within the ophthalmic drug development space, where it conducts clinical trials and collaborates with partners to bring new therapies to market. Its pipeline includes investigational treatments aimed at restoring or preserving vision in diseases such as retinal degeneration and inflammation.Read More